The National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, is working with regulatory authorities to get approval for a nebulizer-based inhalation therapy it has designed for use in COVID patients.
The inhalation therapy for combating COVID-19 is very effective. “We are working with regulatory authorities to get clearance. We have done some clinical studies and hopefully, we will be getting a nod for conducting phase I human trials,” NIPER Hyderabad director Shashi Bala Singh said on Wednesday.
Addressing a virtual conference ‘Pharm-Exe’ organised by the Confederation of Indian Industry (CII) with IMT Hyderabad, Ms. Singh mentioned the therapy as well as the re-purposing of two drugs, another project of NIPER, in the context of the need for enhanced industry-academia collaboration.
A release from CII said Ms. Singh said that 30% of the research in India is being conducted as part of industry-academia collaboration whereas globally it is close to